Sign for Notice Everyday    Sign Up| Sign In| Link|

Our Sponsors

Receive Latest News

Share Us

TMB & Neoantigen Congress

View: 341

Website | Edit Freely

Category Oncology; TMB; immuno-oncology; Neoantigen

Deadline: October 04, 2019 | Date: October 10, 2019-October 11, 2019

Venue/Country: London Heathrow Marriott Hotel, Bath Road Heathrow, U.K.

Updated: 2019-01-08 22:32:55 (GMT+9)

Call For Papers - CFP


One of the key advantages of immuno-oncology is the potential to offer targeted personalized care for patients. However, challenges remain in matching patients to the therapies that offer the greatest chance of success, limiting efficacy depending on individual circumstances and increasing costs. Thus technologies that can assist in guiding therapies are vital – a role filled by predicted biomarker and neoantigen research.

This conference will explore the latest research on the tumour mutation burden and its potential for demonstrating the viability of immunotherapeutic treatment, as well as the development of other predictive biomarkers. A dedicated session will also examine the growing potential of neoantigens as novel targets for precision medicine.

Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.